title: Phenprocoumon and acenocoumarol treatment in paediatric patients.
authors.forename: Nienke
authors.initials: N
authors.lastname: Spoor
authors.forename: Frans J
authors.initials: FJ
authors.lastname: Smiers
authors.forename: Felix J M
authors.initials: FJ
authors.lastname: van der Meer
authors.forename: Barbara A
authors.initials: BA
authors.lastname: Hutten
authors.forename: C Heleen
authors.initials: CH
authors.lastname: van Ommen
mesh_terms: D000074:Acenocoumarol / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000293:Adolescent; D000367:Age Factors; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D019934:International Normalized Ratio; D008297:Male; D010644:Phenprocoumon / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012189:Retrospective Studies; D014812:Vitamin K / Q000037:antagonists & inhibitors
chemical_list: D000925:Anticoagulants; D014812:Vitamin K; D000074:Acenocoumarol; D010644:Phenprocoumon